LumaCyte Accelerates Global Growth, Closing Strategic Series B Financing
LumaCyte, an advanced bioanalytical instrumentation leader for rapid label-free cellular analytics, announced the closing of a B series financing that will further accelerate growth in the company’s automated bioproduction analytics solutions and expand its global infrastructure to meet growing demand. The financing was led by Malvern Panalytical, an international leader......